JPX:4599

StemRIM · JPX · Healthcare · JPY · FY for 2026

Figures on this page computed 2026-11-08 13:09 UTC

Last close

n/aJPY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed

4 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

783

2017-07-31 to 2023-07-31100 at the start783

Sales: 100.00 on 2017-07-31 to 783.33 on 2023-07-31, up 683%.

Shares in issue

124

2017-07-31 to 2026-07-31100 at the start124

Shares in issue: 100.00 on 2017-07-31 to 124.27 on 2026-07-31, up 24%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 783, Shares in issue is at 124, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 100783
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Profit, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Shares in issue, where the first year is 100124
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY